Choose a language and wait for the translated text.
CSPC is eligible to receive $30 million as an upfront payment and up to about $1.74 billion in additional payments tied to development and sales-related milestones
AstraZeneca signs CSPC China deal for experimental kidney disease drugs | PharmaVoice
